StemCyte, Inc.
Records under this name other than the patents StemCyte, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 2 of 2 · Back to StemCyte, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,062,837 | Plasma-Depleted, Not Erythrocyte-Depleted, Cord Blood Compositions and Method of Making Term ended Term ended Jun 2, 2026 · High confidence | Term ended | Term ended Jun 2, 2026 | High confidence |
| US 6,670,124 | High throughput methods of HLA typing Lapsed on the fee record Ended Dec 30, 2015 · From the USPTO record | Lapsed on the fee record | Ended Dec 30, 2015 | From the USPTO record |